HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stanley J Szefler Selected Research

anti-IgE antibodies

1/2020Treatment Benefit with Omalizumab in Children by Indicators of Asthma Severity.
5/2017Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience.
1/2016Advances in asthma 2015: Across the lifespan.
6/2015Seasonal risk factors for asthma exacerbations among inner-city children.
3/2013Reassessment of omalizumab-dosing strategies and pharmacodynamics in inner-city children and adolescents.
3/2012Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescents.
3/2011Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.
9/2009Baseline characteristics of patients enrolled in EXCELS: a cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stanley J Szefler Research Topics

Disease

196Asthma (Bronchial Asthma)
12/2022 - 01/2002
18Inflammation (Inflammations)
01/2021 - 08/2002
12Respiratory Sounds (Crackle)
01/2019 - 12/2004
10Hypersensitivity (Allergy)
09/2017 - 04/2002
6Airway Obstruction (Choking)
02/2014 - 08/2002
3Infections
10/2017 - 07/2004
3Neoplasms (Cancer)
05/2017 - 12/2010
3Cataract (Cataracts)
12/2016 - 09/2003
3Respiratory Hypersensitivity
10/2010 - 08/2009
2Eczema
01/2019 - 08/2014
2Respiratory Tract Infections (Respiratory Tract Infection)
02/2018 - 07/2004
2Eosinophilia
02/2018 - 12/2004
2Virus Diseases (Viral Diseases)
10/2017 - 09/2017
2Lung Diseases (Lung Disease)
12/2015 - 04/2013
2Chronic Obstructive Pulmonary Disease (COPD)
04/2013 - 10/2010
1Confusion (Bewilderment)
01/2020
1Obesity
01/2018
1Overweight
01/2018
1Open-Angle Glaucoma (Glaucoma, Open Angle)
12/2016
1Pain (Aches)
08/2016
1Fever (Fevers)
08/2016
1Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome
09/2015
1Leukemia
11/2014
1Body Weight (Weight, Body)
03/2013

Drug/Important Bio-Agent (IBA)

79Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021 - 03/2002
25Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2004
22Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2020 - 05/2003
18Immunoglobulin E (IgE)IBA
07/2020 - 09/2002
18Budesonide (Pulmicort)FDA LinkGeneric
01/2013 - 04/2002
17Bronchodilator Agents (Bronchodilators)IBA
05/2021 - 09/2002
16Fluticasone (Cutivate)FDA LinkGeneric
12/2021 - 06/2004
15Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
04/2017 - 02/2007
15montelukast (Singulair)FDA Link
01/2013 - 02/2003
14Omalizumab (Xolair)FDA Link
11/2021 - 09/2009
14Tiotropium Bromide (Spiriva)FDA Link
12/2020 - 10/2010
12Salmeterol Xinafoate (Serevent)FDA Link
12/2016 - 04/2005
12Albuterol (Salbutamol)FDA LinkGeneric
08/2016 - 09/2002
11AllergensIBA
07/2019 - 09/2002
11GlucocorticoidsIBA
01/2019 - 08/2002
10SteroidsIBA
01/2020 - 01/2002
8Biological ProductsIBA
01/2021 - 11/2003
8anti-IgE antibodiesIBA
01/2020 - 09/2009
8Methacholine Chloride (Methacholine)FDA Link
01/2011 - 09/2002
6Beclomethasone (Beclometasone)FDA Link
07/2015 - 06/2002
6SuspensionsIBA
01/2013 - 04/2002
6Nedocromil (Alocril)FDA Link
02/2010 - 05/2003
5Pharmaceutical PreparationsIBA
12/2021 - 05/2003
5SmokeIBA
01/2019 - 07/2002
4LeukotrienesIBA
03/2014 - 04/2007
3Acetaminophen (Paracetamol)FDA LinkGeneric
01/2021 - 08/2016
3Prednisone (Sone)FDA LinkGeneric
01/2020 - 09/2004
3Arginine (L-Arginine)FDA Link
01/2018 - 03/2006
3Immunologic Factors (Immunomodulators)IBA
03/2015 - 01/2008
2Ibuprofen (Motrin)FDA LinkGeneric
01/2021 - 08/2016
2MacrolidesIBA
02/2018 - 04/2017
2CytokinesIBA
04/2017 - 08/2002
2Cholinergic Antagonists (Anticholinergics)IBA
02/2017 - 10/2010
2Interleukin-4 (Interleukin 4)IBA
07/2015 - 08/2002
2Interleukin-13IBA
07/2015 - 08/2013
2RNA (Ribonucleic Acid)IBA
07/2015 - 02/2011
2arginylarginine (Arg-Arg)IBA
11/2009 - 10/2004
2Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2009 - 03/2006
2Indicators and Reagents (Reagents)IBA
09/2008 - 09/2002
2Eosinophil Cationic ProteinIBA
09/2004 - 05/2003
2AerosolsIBA
07/2002 - 06/2002
13- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA
01/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2020
1Triamcinolone (Aristocort)FDA Link
01/2020
1Muscarinic AntagonistsIBA
01/2019
1Mometasone Furoate (Nasonex)FDA LinkGeneric
01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
02/2018
1Glutathione (Reduced Glutathione)IBA
01/2018
1Monoclonal AntibodiesIBA
04/2017
1Orosomucoid (Seromucoid)IBA
01/2016
1Cadherins (E-Cadherin)IBA
01/2016
1Fluticasone-Salmeterol Drug Combination (Advair)FDA Link
01/2016
1reslizumabIBA
01/2016
1mepolizumabIBA
01/2016
1DNA (Deoxyribonucleic Acid)IBA
07/2015
1ChromatinIBA
11/2014
1Formaldehyde (Formol)FDA Link
11/2014
1Vitamin DFDA LinkGeneric
05/2014
1cysteinyl-leukotrieneIBA
02/2014
1Cholinergic Agents (Cholinergics)IBA
11/2013
1Interleukin-33IBA
08/2013
1P-2 (P 2)IBA
08/2013
1Genetic Markers (Genetic Marker)IBA
01/2013
1NucleotidesIBA
01/2013
1Kv Channel-Interacting Proteins (Calsenilin)IBA
01/2013
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
12/2012

Therapy/Procedure

97Therapeutics
01/2022 - 01/2002
10Nebulizers and Vaporizers (Inhaler)
12/2022 - 05/2002
5Precision Medicine
01/2021 - 12/2011
5Biological Therapy
01/2020 - 12/2016
2Drug Therapy (Chemotherapy)
12/2017 - 03/2005
2Ambulatory Care (Outpatient Care)
09/2016 - 05/2002
2Metered Dose Inhalers (Metered Dose Inhaler)
06/2004 - 06/2002
1Immunotherapy
12/2016
1Tertiary Prevention
12/2016
1Critical Care (Surgical Intensive Care)
12/2015